Baba Vision
PrivateLast Round
Accelerator
Oct 14, 2024
Total Funding Raised
$300,000
Company Overview
Baba Vision is a health technology company that provides an AI-driven decision support tool for personalized Alzheimer's diagnostics and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Precision Medicine, Vertical SaaS, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baba Vision Comparables
Compare Baba Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| In-Med Prognostics | 79% | |
| Qynapse | 77% | |
| Darmiyan | 77% | |
Baba Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 14, 2024 |
Baba Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aleap | Accelerator |
| Startuplab Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2024
$300K raised from Aleap and StartupLab.
Baba Vision Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Baba Vision's valuation, stock price, and market status.